Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Asia

Asia Pharmaceuticals & Healthcare Insight provides country-by-country analysis of the key trends impacting the prescription, OTC and generic drugs industries across Asia. Asia Pharmaceuticals & Healthcare Insight includes competitive intelligence on the growth strategies of leading national and multinational companies, along with 5-year industry forecasts for each country. The service includes access to the very latest analysis, a searchable archive of articles and data and the ability to download PDFs of current and back issues.

›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.

›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.


Latest Stories

South Korea / Industry

The halt of yet another clinical trial for a biosimilar of Roche's Rituxan (rituximab) highlights the regulatory issues biosimilars are currently experiencing. The delay will benefit biologics manufacturers such as Roche, as their market shares will threatened by biosimilars but remain relatively secure for now.

2013-04-29

Japan / Industry

Through their involvement in this growing trend, Shionogi, Daiichi Sankyo, Astellas Pharma, Takeda and Eisai can expect to reap huge reputational benefits, as well as access to knowledge... 2013-04-26


Myanmar / Industry

We highlight the difficulty Myanmar will face in healthcare financing, given the country's high burden of communicable and non-communicable diseases. The situation is made worse by... 2013-04-25


Industry Developments

South Korea

The halt of yet another clinical trial for a biosimilar of Roche's Rituxan (rituximab) highlights the regulatory issues biosimilars are currently experiencing. The delay will benefit... 2013-04-29


Japan

Through their involvement in this growing trend, Shionogi, Daiichi Sankyo, Astellas Pharma, Takeda and Eisai can expect to reap huge reputational benefits, as well as access to knowledge... 2013-04-26


Myanmar

We highlight the difficulty Myanmar will face in healthcare financing, given the country's high burden of communicable and non-communicable diseases. The situation is made worse by... 2013-04-25


Japan

Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated. BMI's Pharmaceutical Expenditure Model reveals... 2013-04-24